HOME
Curriculum Vitae
pharmaceutical Consultant
Expert & Expert Witness Experience
Academia, Licensure, Professional and Scientific Affiliations
PublicationS
External resources
Contact Information
Links
Links
Chrzanowski FA, Ahmad K. The Preparation and Evaluation of Salt Forms of Linogliride with Reduced Solubilities as Candidates for Controlled Release. Drug Dev and Ind Pharm (IDDI) 2016;32:1-37. Epub 216 Nov 3. doi:10.1080/03639045.2016.1257019.
Chrzanowski FA. Preformulation Considerations for Controlled Release Dosage Forms. Part I: Selecting Candidates. AAPS PharmSciTech 2008 June; 9(2):635-8. Epub 2008 Mar 28 doi: 10.1208/s12249-008-9068-2.
Chrzanowski FA. Preformulation Considerations for Controlled Release Dosage Forms. Part II: Selected Candidate Support. AAPS PharmSciTech 2008 June;9(2):639-45. Epub 2008 Mar 29 doi: 10.1208/s12249-008-9067-3.
Chrzanowski FA. Preformulation Considerations for Controlled Release Dosage Forms. Part III Candidate Form Selection Using Numerical Weighting and Scoring. AAPS PharmSciTech 2008 June; 9(2): 646–650. Epub 2008 May 24. doi: 10.1208/s12249-008-9069-1.
Chrzanowski FA, McGrogan BA, Maryanoff BE. The pKa of Butaclamol and the Mode of Butaclamol Binding to Central Dopamine Receptors. J Med Chem 1985;28:399-400.
Chrzanowski FA, Evans L, Nguyen M, Fegely B, Koch T. The Vapor Pressure of Topiramate, naphthalene and benzoic acid. Int J Appl Biotech Pharm Tech 2016 Jan-Mar, 7(1):267-274.
Walkling WD, Chrzanowski FA, Egan RS, Ko CY, Paragamian V, Mills JE, Plampin JN. Fenoctimine Sulfate Hydration. Drug Devel and Ind Pharm 1984;10:241-258.
Chrzanowski FA, Fegely BJ, Sisco WR, Newton MP. Analysis of N-(4-hydroxyphenyl)retinamide Polymorphic Forms by X-ray Powder Diffraction. J Pharm Sci 1984;73:1448-1450.
Chrzanowski FA, Ulissi LA, Fegely BJ, Newman AC. Preformulation Excipient Compatibility Testing. Application of a Differential Scanning Calorimetric Method versus a Wet Granulation Simulating, Isothermal Stress Method. Drug Dev and Ind Pharm 1986;12:783-800.
Radd BL, Newman AC, Fegely BJ, Chrzanowski FA, Lichtin JL, Walkling WD. Development of Haloperidol in oil Formulation. J Parent Sci and Tech 1985;38:48-51.
Walkling WD, Chrzanowski FA, Mamajek RC, Fegely BJ, Mobley NE, Ulissi LA. Solubilization of Zomepirac. J Parent Sci and Tech 1982;36:190-192.
Chrzanowski FA, Kolod IM, Ahlswede BA, Fegely BJ. A Method for Evaluating the Corrosion Potential of a Tablet Press Turret by Drug Substances, Granulations, and Powder Blends. Drug Dev and Ind Pharm 1986;12:2381-2385.
Walkling WD, Sisco WR, Newton MP, Fegely BJ, Chrzanowski FA. Stability of Fenretinide Polymorphs. Acta Pharm Technol 1986;32:10-12.
